About Murthy Chavali
Murthy Chavali is a director at 65 Therapeutics.
Murthy Chavali first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Murthy Chavali in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Murthy Chavali works with at each company, as listed on that company's latest Form D.
65 Therapeutics, Inc. · Form D/A, Jul 6, 2026
JK
Julius Knowles
President and director